Bret Campbell is a partner in the White Collar Defense and Investigations group in the Washington, D.C., office. Bret represents clients in a broad range of complex criminal, regulatory, and civil litigation matters involving international corruption and the Foreign Corrupt Practices Act, money laundering and export controls, as well as securities, healthcare, accounting, and commercial fraud. He has extensive experience managing internal corporate investigations and cross-border criminal and regulatory matters, often in proceedings before the U.S. Department of Justice and the U.S. Securities and Exchange Commission.
In addition to his litigation practice, Bret conducts FCPA and regulatory compliance due diligence reviews in connection with mergers, acquisitions, and other complex corporate transactions. He has directed numerous global due diligence reviews of proposed investments and business combinations in industries and jurisdictions presenting significant risks of corruption and fraud.
Bret also advises clients on corporate governance issues and on the implementation of compliance codes. He helps companies assess risks in their international operations, and counsels on the development and implementation of policies, procedures, and systems designed to prevent and detect potential violations of law. Bret regularly provides training on FCPA and related issues to his clients' legal, compliance and internal audit departments.
Bret writes and speaks frequently on regulatory, criminal law, and compliance issues, and serves as a faculty member of Seton Hall Law School's Healthcare Compliance Certification Program. He has spoken at events for the American Conference Institute, the Pharmaceutical Compliance Congress and Best Practices Forum, the Practising Law Institute, the Society of Corporate Compliance and Ethics, the Pharmaceutical Internal Audit Forum, and has co-chaired the American Conference Institute's annual conference on FCPA & Anti-Corruption for the Life Sciences Industry.
He received a B.A., with honors, in 1989 from Hobart College, and a J.D., cum laude, in 1994 from Vermont Law School. Bret is admitted to practice in the District of Columbia, the State of New York, and the U.S. District Court for the District of Columbia.
• Cadwalader Launches Health Care Fraud Strike Force
Jun 24, 2015
• Travel Agencies, Fapiao and Hospitality: $12.8 Million SciClone Settlement Highlights Diversity of Risk in China
Feb 10, 2016
• 2012 Burton Awards for Legal Achievement
Jun 12, 2012
Clients & Friends Memos
• UK Financial Conduct Authority Issues Final Rules Concerning Whistleblowers
Oct 14, 2015
• UK Issues Sentencing Guideline for Individuals Convicted of White-Collar Offenses
Aug 01, 2014
• ACI's 10th Advanced Forum on FCPA & Anti-Corruption for the Life Sciences Industry
Apr 27, 2016
• Paper Tigers: Recent Settlements Show Companies Operating in China Need to Do More to Enforce FCPA Policies
Mar 02, 2016
SEC Enforcement Advisor
• SEC Announces Largest Ever Whistleblower Award, Awards $30 Million to Foreign Whistleblower
Oct 01, 2014
White Collar Defense and Investigations Advisor
• AML Guidance Issued for Banks Seeking to Service Marijuana-Related Businesses
Feb 27, 2014